top of page

Market Access

Enabling patients’ access to therapies requires authorization from health authorities and payers’ acceptance of pricing based on therapy’s benefits and advantages over existing options. The pricing is driven by insights from key opinion leaders, prescribers’ understanding of the therapy, payers’ policies and regulatory framework on certain disease areas in the country.

 

The key benefits and advantages over existing treatments are part of drug development planning and therefore, it can be stated that Market Access is a key consideration right from the early stage of drug development.

 

Artixio’s team brings wealth of experience across complex therapeutic areas and global markets to help you address key questions for your market access strategy –

pricing and reimbursement market access consultant pharmaceutical medical devices biologics usa ema india singapore japan

Market Access

​Pricing

Price comparator with existing therapies under applicable treatment setups to assess ‘effective cost of treatment’ through the lifecycle of treatment
KOL opinion on new therapy’s advantages and benefits over current options
Targeting expected indication and therapy



 
Risks based on side effects




 
Existing therapeutic modalities and line of therapy



 
Scientific data supporting product’s advantages



 

Reimbursement

Reimbursement policies in the country

 
Timeline and process for reimbursement approvals

 
Identification of primary markets for product launch based in reimbursement scenario
​​Get in touch with our team to discuss your market access needs.
Contact Us
pricing and reimbursement market access consultant pharmaceutical medical devices biologics china malaysia taiwan singapore

Get in touch

Our experts will be delighted to assist you with your global business needs.

bottom of page